Mahkam Zanganeh - Co-Chief Executive Officer, Director, 10%+ Owner at Summit Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Co-Chief Executive Officer, Director, 10%+ Owner
Issuer Symbol
SMMT on Nasdaq
All Insider Reports
All Insider Reports

Mahkam Zanganeh - trading volume in the past year for Summit Therapeutics Inc.

Holdings reported by Mahkam Zanganeh for Summit Therapeutics Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 570,073,879 $10,683,184,492 $18.74 21 Oct 2025 By Spouse
Common Stock 25,724,474 $482,076,642 $18.74 21 Oct 2025 By the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee
Common Stock 10,199,776 $210,727,372 $20.66 21 Oct 2025 By the Shaun Zanganeh Irrevocable Trust, with the Reporting Person as Trustee
Common Stock 76,680 $1,436,983 $18.74 21 Oct 2025 Immediate family member
Common Stock 31,000 $640,460 $20.66 21 Oct 2025 Direct
Stock Option (right to buy) 11,232 $98,392 $8.76 02 Jan 2026 By Spouse Common Stock
Stock Option (right to buy) 9,590,558 29 Apr 2025 Direct Common Stock
Warrant (right to buy) 0 08 Apr 2025 By Spouse Common Stock 3,985,055

Transactions reported by Mahkam Zanganeh for Summit Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.